Discover
CRNX
Crinetics Pharmaceuticals, Inc.
38.68
2 x 27.85
2 x 48.62
bid
ask
+
1.26
3.37%
2 @ 06:07 AM
39.70 +1.02 (2.64%)
| Ytd | -16.91% | |
| 1y | 36.05% |
37.37
day range
39.40
25.83
52 week range
57.99
| Open | 37.49 | Prev Close | 37.42 | Low | 37.37 | High | 39.40 | Mkt Cap | 4.08B |
| Vol | 1.13M | Avg Vol | 1.21M | EPS | -5.14 | P/E | N/A | Forward P/E | -8.89 |
| Beta | 0.24 | Short Ratio | 13.44 | Inst. Own | 120.18% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 36.72 | 200-d Avg | 41.80 | 1yr Est | 83.14 |
| Income Statement | |||
| Total Revenue | 10.73M | ||
| Revenues (USD) | 10.73M | ||
| Cost of Revenue | 200.00K | ||
| Gross Profit | 10.53M | ||
| Operating Expenses | 150.91M | ||
| Research and Development Expense | 100.08M | ||
| Selling, General and Administrative Expense | 50.83M | ||
| Operating Income | -140.38M | ||
| Net Income | -127.84M | ||
| Net Income Common Stock | -127.84M | ||
| Net Income Common Stock (USD) | -127.84M | ||
| Consolidated Income | -127.84M | ||
| Earnings per Basic Share | -1.23 | ||
| Earnings per Basic Share (USD) | -1.23 | ||
| Earnings per Diluted Share | -1.23 | ||
| Earning Before Interest & Taxes (EBIT) | -127.84M | ||
| Earning Before Interest & Taxes (USD) | -127.84M | ||
| Weighted Average Shares | 104.10M | ||
| Weighted Average Shares Diluted | 104.10M | ||
| Balance Sheet | |||
| Cash and Equivalents | 114.34M | ||
| Cash and Equivalents (USD) | 114.34M | ||
| Investments | 1.18B | ||
| Investments Current | 1.18B | ||
| Investments Non-Current | 800.00K | ||
| Trade and Non-Trade Receivables | 5.68M | ||
| Current Assets | 1.32B | ||
| Property, Plant & Equipment Net | 53.29M | ||
| Total Assets | 1.40B | ||
| Debt Current | 6.54M | ||
| Total Debt | 47.86M | ||
| Current Liabilities | 71.09M | ||
| Debt Non-Current | 41.32M | ||
| Total Liabilities | 120.68M | ||
| Accumulated Retained Earnings (Deficit) | -1.55B | ||
| Accumulated Other Comprehensive Income | -1.25M | ||
| Shareholders Equity | 1.28B | ||
| Shareholders Equity (USD) | 1.28B | ||
| Assets Non-Current | 78.91M | ||
| Total Debt (USD) | 47.86M | ||
| Deferred Revenue | 4.62M | ||
| Inventory | 3.06M | ||
| Liabilities Non-Current | 49.59M | ||
| Trade and Non-Trade Payables | 37.49M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.86M | ||
| Net Cash Flow from Financing | 389.88M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 12.81M | ||
| Capital Expenditure | -820.00K | ||
| Issuance (Purchase) of Equity Shares | 390.45M | ||
| Net Cash Flow from Investing | -252.36M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -251.54M | ||
| Net Cash Flow from Operations | -124.70M | ||
| Share Based Compensation | 29.68M | ||